Abstract |
|
Authors | Hiroshi Kobayashi, Tatsuo Yagyu, Toshiharu Kondo, Noriyuki Kurita, Kiyokazu Inagaki, Shoji Haruta, Ryuji Kawaguchi, Takashi Kitanaka, Yoshiharu Sakamoto, Yoshihiko Yamada, Naohiro Kanayama, Toshihiko Terao |
Journal | Cancer research
(Cancer Res)
Vol. 65
Issue 22
Pg. 10464-71
(Nov 15 2005)
ISSN: 0008-5472 [Print] United States |
PMID | 16288038
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- NF-kappa B
- PLAUR protein, human
- Plaur protein, mouse
- RNA, Messenger
- Receptors, Cell Surface
- Receptors, Urokinase Plasminogen Activator
- TGFB1 protein, human
- Tgfb1 protein, mouse
- Transforming Growth Factor beta
- Transforming Growth Factor beta1
- Thalidomide
- Urokinase-Type Plasminogen Activator
- Paclitaxel
|
Topics |
- Animals
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Cell Line, Tumor
- Chondrosarcoma
(drug therapy, metabolism, pathology)
- Drug Synergism
- Female
- Gene Expression
(drug effects)
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Ovarian Neoplasms
(drug therapy, metabolism, pathology)
- Paclitaxel
(administration & dosage, pharmacology)
- RNA, Messenger
(biosynthesis, genetics)
- Receptors, Cell Surface
(antagonists & inhibitors, biosynthesis, genetics)
- Receptors, Urokinase Plasminogen Activator
- Thalidomide
(administration & dosage, pharmacology)
- Transforming Growth Factor beta
(pharmacology)
- Transforming Growth Factor beta1
- Urokinase-Type Plasminogen Activator
(antagonists & inhibitors, metabolism)
- Xenograft Model Antitumor Assays
|